Insiders who reported open-market trades in the last 12 months at the companies Vincent Vultaggio files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
WALTERS GROUP - $22.92M in ZNTL purchases and sales in the last 12 months
Vincent Vultaggio is a corporate insider, tracked as PAO and PFO of Zentalis Pharmaceuticals, Inc. (ZNTL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Vincent Vultaggio last file a Form 4?
The most recent primary Form 4 on record is dated 11 February 2026, one of 3 filings going back to 2024.
Has Vincent Vultaggio been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($111K) across all tracked filings.
Vincent Vultaggio is PAO and PFO of Zentalis Pharmaceuticals, Inc. (ZNTL). 3 SEC Form 4 filings on record going back to 2024, most recently on 11 February 2026. Most recent open-market trade: sold $17K of ZNTL on 11 February 2026. Lifetime open-market sales: $111K.
Recent transactions
6
The latest 6 SEC Form 4 transactions reported by Vincent Vultaggio.
InsiderAlpha's records for Vincent Vultaggio go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. 6 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
